Literature DB >> 32966710

Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.

Edwin Bölke1, Christiane Matuschek1, Johannes C Fischer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32966710     DOI： 10.1056/NEJMc2027051

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk.

Authors:  Maria Tsilika; Esther Taks; Konstantinos Dolianitis; Antigone Kotsaki; Konstantinos Leventogiannis; Christina Damoulari; Maria Kostoula; Maria Paneta; Georgios Adamis; Ilias Papanikolaou; Kimon Stamatelopoulos; Amalia Bolanou; Konstantinos Katsaros; Christina Delavinia; Ioannis Perdios; Aggeliki Pandi; Konstantinos Tsiakos; Nektarios Proios; Emmanouela Kalogianni; Ioannis Delis; Efstathios Skliros; Karolina Akinosoglou; Aggeliki Perdikouli; Garyfallia Poulakou; Haralampos Milionis; Eva Athanassopoulou; Eleftheria Kalpaki; Leda Efstratiou; Varvara Perraki; Antonios Papadopoulos; Mihai G Netea; Evangelos J Giamarellos-Bourboulis
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 2.  Why current quantitative serology is not quantitative and how systems immunology could provide solutions.

Authors:  József Prechl
Journal:  Biol Futur       Date:  2021-02-20

3.  SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors.

Authors:  Evangelos Terpos; Dimitris Stellas; Margherita Rosati; Theodoros N Sergentanis; Xintao Hu; Marianna Politou; Vassiliki Pappa; Ioannis Ntanasis-Stathopoulos; Sevasti Karaliota; Jenifer Bear; Duncan Donohue; Maria Pagoni; Elisavet Grouzi; Eleni Korompoki; George N Pavlakis; Barbara K Felber; Meletios A Dimopoulos
Journal:  Eur J Intern Med       Date:  2021-05-18       Impact factor: 7.749

4.  Development and longevity of antibodies against SARS-CoV-2 in kidney transplant recipients after symptomatic COVID-19.

Authors:  Divya Bajpai; Deepal Shah; Sreyashi Bose; Satarupa Deb; Chintan Gandhi; Tulsi Modi; Nikhil Rao; Kruteesh Kumar; Nikhil Saxena; Abhinav Katyal; Ankita Patil; Sayali Thakare; Atim E Pajai; Gita Nataraj; Tukaram E Jamale
Journal:  Transpl Infect Dis       Date:  2021-06-01

5.  Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.

Authors:  Varun Sasisekharan; Niharika Pentakota; Akila Jayaraman; Kannan Tharakaraman; Gerald N Wogan; Uma Narayanasami
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

6.  Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.

Authors:  Nathalie Chavarot; Marianne Leruez-Ville; Anne Scemla; Carole Burger; Lucile Amrouche; Claire Rouzaud; Xavier Lebreton; Frank Martinez; Rebecca Sberro-Soussan; Christophe Legendre; Julien Zuber; Dany Anglicheau
Journal:  Kidney Int       Date:  2021-02       Impact factor: 10.612

7.  Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.

Authors:  Natalia Sherina; Antonio Piralla; Likun Du; Hui Wan; Makiko Kumagai-Braesch; Juni Andréll; Sten Braesch-Andersen; Irene Cassaniti; Elena Percivalle; Antonella Sarasini; Federica Bergami; Raffaella Di Martino; Marta Colaneri; Marco Vecchia; Margherita Sambo; Valentina Zuccaro; Raffaele Bruno; Michele Sachs; Tiberio Oggionni; Federica Meloni; Hassan Abolhassani; Federico Bertoglio; Maren Schubert; Miranda Byrne-Steele; Jian Han; Michael Hust; Yintong Xue; Lennart Hammarström; Fausto Baldanti; Harold Marcotte; Qiang Pan-Hammarström
Journal:  Med (N Y)       Date:  2021-02-10

8.  Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.

Authors:  Madhumita Shrotri; Ross J Harris; Alison Rodger; Timothy Planche; Frances Sanderson; Tabitha Mahungu; Alastair McGregor; Paul T Heath; Colin S Brown; Jake Dunning; Susan Hopkins; Shamez Ladhani; Meera Chand
Journal:  Emerg Infect Dis       Date:  2021-03-18       Impact factor: 6.883

9.  A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States.

Authors:  David Alfego; Adam Sullivan; Brian Poirier; Jonathan Williams; Dorothy Adcock; Stanley Letovsky
Journal:  EClinicalMedicine       Date:  2021-05-24

10.  Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure.

Authors:  Adrián Sánchez-Montalvá; Candela Fernández-Naval; Andrés Antón; Xavier Durà; Alba Vimes; Aroa Silgado; Fernando Velásquez-Orozco; Juan Espinosa-Pereiro; Fernando Salvador; Tomás Pumarola; Benito Almirante; Juliana Esperalba
Journal:  J Clin Med       Date:  2021-05-04       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.